Karen D. Quinn, Ph.D.

Head of Regulatory Affairs

Karen is a professional with over 35 years of pharmaceutical industry experience including over 20 years in Global Regulatory Affairs leadership roles, specifically with a focus on drug products with biologically derived active pharmaceutical ingredients.  Former positions include Takeda Pharmaceuticals, Millennium Pharmaceuticals, Solvay Pharmaceuticals and Procter & Gamble Pharmaceuticals.  Currently, she is a regulatory consultant to biotech companies.  She has a doctorate in medicinal chemistry.

Meet More of Our Team
InsuLife is a Norwegian company aiming at bringing the unparalleled developmental INS-2301 skin-applied insulin to market.
Learn More
© Copyright 2024 - InsuLife AS, All Rights Reserved
cross